5-hydroxydopamine has been researched along with quinazolines in 1 studies
| Studies (5-hydroxydopamine) | Trials (5-hydroxydopamine) | Recent Studies (post-2010) (5-hydroxydopamine) | Studies (quinazolines) | Trials (quinazolines) | Recent Studies (post-2010) (quinazolines) |
|---|---|---|---|---|---|
| 71 | 0 | 0 | 19,235 | 2,417 | 8,835 |
| Protein | Taxonomy | 5-hydroxydopamine (IC50) | quinazolines (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.027 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cardo, B; Kempf, E; Velley, L | 1 |
1 other study(ies) available for 5-hydroxydopamine and quinazolines
| Article | Year |
|---|---|
Locomotor activity of rats after stimulation of the nucleus locus coeruleus region or after lesion of the dorsal noradrenergic bundle: effects of clonidine, prazosin and yohimbine.
Topics: Animals; Brain Stem; Cerebral Cortex; Clonidine; Dose-Response Relationship, Drug; Electric Stimulation; Exploratory Behavior; Hippocampus; Hydroxydopamines; Locus Coeruleus; Male; Motor Activity; Neural Pathways; Norepinephrine; Prazosin; Quinazolines; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Yohimbine | 1982 |